ProfileGDS5678 / 1423093_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 5% 5% 5% 5% 5% 5% 5% 5% 5% 5% 5% 5% 5% 5% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.098825
GSM967853U87-EV human glioblastoma xenograft - Control 22.083365
GSM967854U87-EV human glioblastoma xenograft - Control 32.086125
GSM967855U87-EV human glioblastoma xenograft - Control 42.050165
GSM967856U87-EV human glioblastoma xenograft - Control 52.042385
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.122715
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.078895
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.061195
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.061055
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.074515
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.067765
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.064365
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.077575
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.074785